Cayenne Pepper Cataplasm - Safety Study (Munari04)

Cayenne Pepper Cataplasm Application and Potential Side Effects

The beneficial analgesic effects of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper, are commonly used as natural medications to treat painful or aching areas in the case of acute or chronic back pain, and rheumatisms. In Vienna and lower Austria, a Cayenne Pepper Cataplasm (CPC) application containing Cayenne pepper and Kaolin powder in mixed proportion, is commonly used to treat musculoskeletal conditions of pain especially of the low back. However, a concern about the safety of such applications was recently raised.

Therefore, the aims of the present study are to evaluate the effects of 10x 20min CP cataplasm application as a single treatment or in combination with electrical stimulation and massage on selected functional and molecular parameters on i) healthy subjects and ii) subjects suffering from low back pain.

Study Overview

• Status: Completed
• Conditions: Low Back Pain
• Intervention / Treatment: Drug: Cayenne Pepper topical; Device: Electrical stimulation; Procedure: Massage

Detailed Description

Musculoskeletal diseases, such as neck and low back pain, are widespread disorders in many developed countries. Their management is challenging, and it may have mounting socioeconomic burden. Several evidences in the literature demonstrate the efficacy of many therapeutic strategies in the treatment of these conditions, based on pharmacological or surgical interventions. Physical medicine therapies are good alternatives that may have beneficial effects, especially when used as first line of intervention before approaching more expensive pharmacological or invasive medications. The beneficial analgesic effects of Applicatio Epispasticorum of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper (CP), are commonly used as natural medications to treat painful or aching areas in the case of acute or chronic back pain, and rheumatisms. They are also used in pain involving joints caused by osteoarthritis. A galenic preparation composed of rubefacient substances of vegetable origin, which generated vasodilation and increase in blood circulation on the treated areas, was first prescribed in 1909 by Dr. Giuseppe Munari to treat pain of various areas of the locomotive system. He proposed a method based on applications prepared according to his own galenic formula that have become famous all over Italy and Europe. In Vienna and lower Austria, a Munari-like application containing CP and Kaolin powder in mixed proportion, is commonly used to treat musculoskeletal conditions of pain especially of the low back. The research on responses to CPC applications, particularly in combination with other modalities is scarce.

Therefore, the aims of the present study are firstly to evaluate the effects of 10x 20min CP cataplasm application on selected functional and molecular parameters on healthy subjects. Then, the same applications will be used on subjects suffering from low back pain (LBP) - both as a single treatment and in combination with electrical stimulation and massage.

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Phase 2; Phase 1

Contacts and Locations

Study Locations

• Slovakia
  • Bratislava, Slovakia, 81806
    • Facultiy of Physical Education and Sports, Comenius University of Bratislava
• Slovenia
  • Izola, Slovenia, 6310
    • Faculty of Health Sciences

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Chronic low back pain (>3 months)
• Body mass index below 35 kg/mˇ2

Exclusion Criteria:

• pregnancy
• sensibility disorders (e.g. due to neurological disease)
• injuries, open wounds or rash in intervention area
• known hypersensitivity against the applied substances
• HIV, Hepatitis C and other due blood communicable infectious diseases

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Healthy; Healthy participants with no low back pain. 20 min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical) on the back will be administered.	Drug: Cayenne Pepper topical; 20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water; Other Names: Cayenne Pepper Cataplasm application
Experimental: LBP patients - CPC Group; Participants suffering from low back pain (LBP) receiving 10 times (within 3 weeks) 20min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical).	Drug: Cayenne Pepper topical; 20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water; Other Names: Cayenne Pepper Cataplasm application
Experimental: LBP patients - CPC and ES/M Group; Participants suffering from low back pain (LBP) receiving 10 times (within 3 weeks) 20min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical), and half of the subject also receiving 10 min electrical Stimulation and 10 min massage Treatment on the back.	Drug: Cayenne Pepper topical; 20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water; Other Names: Cayenne Pepper Cataplasm application; Device: Electrical stimulation; Electrical stimulation 10min 60Hz biphasic rectangular neuromuscular electrical Stimulation (NMES); Other Names: Neuromuscular Electrical Stimulation (NMES); Procedure: Massage; 10 minutes of classical massage of low back pain area.; Other Names: Classical massage

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in concentration of circulating biomarkers of inflammation, neudroendocrine stress and blood vessel activation	The blood analysis will include standard analysis of hemogram, C-reactive proteins, creatine-kinase, sedimentation, albumin and cortisol. Enzyme-linked immunosorbent assay (ELISA) will include Tumor necrosis factor-Alpha, Interleukin-6, Leukotriene B4 and P-Selectine. Additionally, microRNA analysis will be performed (gene numbers: 1, 21, 23, 25, 103, 126, 133, 146, 155, 199a, 199b, 191, 206, 451.	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Change in systolic and diastolic blood pressure	Systolic and diastolic blood pressure [mmHg], measured at both sides of the body with blood pressure gauge	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Heart rate	Heart rate (bpm), measured with heart rate monitor belt.	Before the application, 45 minutes after 10th application and 48 hours after 10th application

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
36-Item Short Form Survey (SF-36)	The Short Form (36) Health Survey (SF-36) is a patient-reported survey of patient health. It consists of eight scaled scores, which are the weighted sums all questions in their respective section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the higher is the disability.	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Change in pain perception	Pain perception during rest and movement assessed with visual analogue scale (0-10). 0 represents no pain, and 10 represents severe pain.	Before the application, 45 minutes after 10th application and 48 hours after 10th application
EQ-5D- 5L questionnaire	EQ-5D- 5L questionnaire includes following aspects: mobility, care, usual activities, pain/discomfort, anxiety/depression, crosswalk-index, self-feeling of health. Each aspect is evaluated on a 1-5 scale, with following descriptions of levels: having no problems, having slight problems, having moderate problems, having severe problems and being unable to do/having extreme problems. Visual analogue scale is the second part of the questionnaire, asking to mark health status on the day of the interview on a 20 cm vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine".	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Oswestry disability index (ODI)	ODI will be used only in LBP arms (Arm 2 and 3). ODI is commonly used by clinicians and researchers to quantify disability for low back pain.	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Skin Sensory Function	Skin sensory function will be assessed by 2-point discrimination test (which is carried out using two pins, oriented in medial-lateral direction and pressed perpendicularly to the skin, with the medial pin being 3 cm laterally from the L3 spinal process. The subject is asked to report whether he/she felt one or two pins) and mono filament/light touch sensitivity tests (monofilaments calibrated to 0.025, 0.07, 2, 5, and 10 grams The subject is asked to report when he/she felt touching the skin with a monofilament 3 cm laterally from L3 spinal process). The lightest mono filament and the lowest pin inter-distance are take as final outcome measures.	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Flexibility	Assessment of total spine flexibility (forward bend test) and separately for the lumbar part (Schober's test) and thoracic part.	Before the application, 45 minutes after 10th application and 48 hours after 10th application
Skin Temperature	Skin temperature [°C] at the site of application (low back) and at the control part of the body (neck), measured with a laser thermometer.	Before the application, 45 minutes after 10th application and 48 hours after 10th application

Collaborators and Investigators

• Sponsor: University of Primorska
• Collaborators: Comenius University; Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation; S2P, Science to Practice, Ltd.; Wilhelminenspital Vienna
• Investigators: Principal Investigator: Nejc Šarabon, PhD, Faculty of Health Sciences, University of Primorska, Slovenia

Study record dates

Study Major Dates

• Study Start (Actual): March 15, 2016
• Primary Completion (Actual): November 15, 2016
• Study Completion (Actual): December 15, 2016

Study Registration Dates

• First Submitted: February 6, 2018
• First Submitted That Met QC Criteria: February 19, 2018
• First Posted (Actual): February 20, 2018

Study Record Updates

• Last Update Posted (Actual): February 20, 2018
• Last Update Submitted That Met QC Criteria: February 19, 2018
• Last Verified: February 1, 2018

More Information

Terms related to this study

• Keywords: Pain; Low Back Pain; Physical Therapy; Capsicum
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain; Low Back Pain
• Other Study ID Numbers: UP-MunariStudy

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No